Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Cardiology|December 16, 1998
The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failureT B Levine, A B Levine, S J Keteyian, et al.
American Journal of Hypertension|September 30, 1998
Paradoxical hypertension after reversal of heart failure in patients treated with intensive vasodilator therapyT B Levine, A B Levine, M Kathawala, et al.
Clinical Cardiology|August 1, 1997
Reverse remodeling in heart failure with intensification of vasodilator therapyT B Levine, A B Levine, S J Keteyian, et al.
Clinical Cardiology|April 6, 2001
Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failureT B Levine, A B Levine, W G Elliott, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1996
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profileT B Levine, A B Levine, D Goldberg, et al.
The American Journal of Cardiology|August 15, 1996
Impact of medical therapy on pulmonary hypertension in patients with congestive heart failure awaiting cardiac transplantationT B Levine, A B Levine, D Goldberg, et al.
American Heart Journal|December 1, 1996
Clinical status of patients removed from a transplant waiting list rivals that of transplant recipients at significant cost savingsT B Levine, A B Levine, A D Goldberg, et al.
The American Journal of Cardiology|January 1, 1997
Acute reversibility of pulmonary hypertension predicts neither long-term hemodynamic response nor outcome in patients awaiting heart transplantationT B Levine, A B Levine, A D Goldberg, et al.
Pageof 1